Literature DB >> 8831060

Effects on salivary flow rate and composition of withdrawal of and re-exposure to the beta 1-selective antagonist metoprolol in a hypertensive patient population.

T Nederfors1, C Dahlöf.   

Abstract

Secretion rates and composition of unstimulated and chewing-stimulated whole saliva and 3% citric acid stimulated parotid and submandibular-sublingual secretions were studied in 12 hypertensive patients during withdrawal of and re-exposure to antihypertensive pharmacotherapy. All the patients' blood pressures were well controlled by monotherapy with metoprolol, a beta 1-selective adrenoceptor antagonist. Blood pressure measurements and saliva sampling were performed at about 9:30 a.m., 2 h after intake of breakfast, on days 0 (medicated baseline), 7, 14, 28 (nonmedicated experimental values and nonmedicated baseline) and 35 (medicated experimental values). A significant increase in unstimulated whole saliva secretion rate was observed when metoprolol was withdrawn and a corresponding decrease when the drug was reintroduced. A positive correlation was found between diastolic blood pressure levels and chewing-stimulated whole saliva secretion rates. In unstimulated whole saliva and 3% citric acid stimulated submandibular-sublingual secretion, the output of total protein, amylase, potassium, calcium and phosphate was significantly increased during the withdrawal period and decreased when metoprolol was reintroduced. For chewing-stimulated whole saliva, the corresponding changes were restricted to output of total protein and amylase, while for citric acid stimulated parotid secretion, no changes in salivary composition were observed. Finally, in all secretions one or both of the ratios hexosamine/total protein and sialic acid/total protein were affected, indicating a possible effect of beta-adrenoceptor antagonists on salivary protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831060     DOI: 10.1111/j.1600-0722.1996.tb00076.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  6 in total

1.  Information for physicians and pharmacists about drugs that might cause dry mouth: a study of monographs and published literature.

Authors:  Caroline T Nguyen; Michael I MacEntee; Barbara Mintzes; Thomas L Perry
Journal:  Drugs Aging       Date:  2014-01       Impact factor: 3.923

Review 2.  Xerostomia and hyposalivation: causes, consequences and treatment in the elderly.

Authors:  T O Närhi; J H Meurman; A Ainamo
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

3.  Saliva profiles in children using heart failure medication: a pilot study.

Authors:  L Rosén; A Rydberg; I Sjöström; C Stecksén-Blicks
Journal:  Eur Arch Paediatr Dent       Date:  2010-08

Review 4.  Salivary carbonic anhydrase isoenzyme VI.

Authors:  J Kivela; S Parkkila; A K Parkkila; J Leinonen; H Rajaniemi
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

5.  Hyperreactivity of Salivary Alpha-Amylase to Acute Psychosocial Stress and Norepinephrine Infusion in Essential Hypertension.

Authors:  Lisa-Marie Walther; Roland von Känel; Claudia Zuccarella-Hackl; Petra H Wirtz
Journal:  Biomedicines       Date:  2022-07-21

6.  Pain intensity and salivary α-amylase activity in patients following mandibular third molar surgery.

Authors:  Wanvipa Surin; Piyanart Chatiketu; Nuntouchaporn Hutachok; Somdet Srichairatanakool; Vuttinun Chatupos
Journal:  Clin Exp Dent Res       Date:  2022-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.